<DOC>
	<DOCNO>NCT00004416</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare efficacy two dos botulinum toxin treatment achalasia . II . Compare safety two dose patient .</brief_summary>
	<brief_title>Randomized Study Botulinum Toxin Type A Achalasia</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , dose response study . Patients randomize one two treatment arm ; arm receives different dose botulinum toxin type A . All patient undergo flexible upper gastrointestinal endoscopy . Botulinum toxin inject low esophageal sphincter 4 quadrant . Some patient may receive second treatment , depend response and/or time relapse . Patients follow daily 7 day , every 1-6 month 1-2 year treatment . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Esophageal Achalasia</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis achalasia esophageal manometry upper endoscopy Symptomatic include dysphagia , regurgitation , etc . No esophageal ulcer , Barrett 's esophagus , significant esophagitis , esophageal varix Patient Characteristics Hematopoietic : Platelet count least 50,000/mm3 Hepatic : PT great 3 second No severe hepatic problem Renal : No severe renal problem Cardiovascular : No recent myocardial infarction No unstable angina No decompensated congestive heart failure Pulmonary : No severe pulmonary disease dyspnea rest Other : No altered mental status No serious systemic disease Not pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2001</verification_date>
	<keyword>achalasia</keyword>
	<keyword>gastrointestinal disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>